🇯🇵 Lutathera in Japan

PMDA authorised Lutathera on 23 June 2021

Marketing authorisation

PMDA — authorised 23 June 2021

  • Marketing authorisation holder: FUJIFILM TOYAMA CHEMICAL Co., Ltd.
  • Status: approved

Lutathera in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Japan

Frequently asked questions

Is Lutathera approved in Japan?

Yes. PMDA authorised it on 23 June 2021.

Who is the marketing authorisation holder for Lutathera in Japan?

FUJIFILM TOYAMA CHEMICAL Co., Ltd. holds the Japanese marketing authorisation.